Novo Nordisk Considers Move Towards Gene Therapy

Bookmark
(Bloomberg) -- Novo Nordisk A/S, the maker of diabetes drugs grappling with U.S. pricing pressure, said it’s considering entering the fast-growing gene therapy field through potential partnerships.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.